Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Staphylococcal Infections

quinazolines has been researched along with Staphylococcal Infections in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaul, M; LaVoie, EJ; Parhi, AK; Pilch, DS; Pradhan, P; Saionz, KW; Trivedi, K; Zhang, Y1
Brown-Driver, V; Cunningham, ML; Finn, J; Hilgers, MT; Hough, G; Kwan, BP; Lam, T; Nelson, KJ; Ong, V; Shaw, KJ; Trzoss, M1
Burda, WN; Fleeman, R; Manetsch, R; Shaw, LN; Van Horn, KS1
Del Giudice, P; Delord, JP; Hubiche, T; Roché, H; Sibaud, V; Tournier, E1
Garófalo, A; Giai, C; Gómez, MI; Gonzalez, CD; Ledo, C1
Kaley, K; Li, J; Peccerillo, J; Saif, MW1
Chu, DS; Johnson, KS; Levin, F1
Amitay-Laish, I; David, M; Stemmer, SM1
Gipps, M; Goldberg, A; Grenader, T1
Ashbel, SI; Bogoslovskaia, IA; Filiushina, ZG; Khil, RG; Sokolova, VG1

Other Studies

10 other study(ies) available for quinazolines and Staphylococcal Infections

ArticleYear
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.
    Bioorganic & medicinal chemistry letters, 2013, Sep-01, Volume: 23, Issue:17

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Naphthyridines; Quinazolines; Quinoxalines; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2013
Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines.
    Journal of medicinal chemistry, 2014, Feb-13, Volume: 57, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Bacterial; Folic Acid Antagonists; Humans; Mice; Microbial Sensitivity Tests; Models, Molecular; Quinazolines; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase

2014
Antibacterial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines.
    Journal of medicinal chemistry, 2014, Apr-10, Volume: 57, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Diamines; Disease Models, Animal; Hemolysis; Humans; Larva; Microbial Sensitivity Tests; Molecular Structure; Peritonitis; Quinazolines; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship

2014
Late epidermal growth factor receptor inhibitor-related papulopustular rash: a distinct clinical entity.
    Clinical and experimental dermatology, 2016, Volume: 41, Issue:1

    Topics: Adult; Aged; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pruritus; Quinazolines; Skin Diseases, Papulosquamous; Staphylococcal Infections; Staphylococcus aureus

2016
The Sbi Protein Contributes to Staphylococcus aureus Inflammatory Response during Systemic Infection.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Animals; Bacterial Proteins; Binding Sites, Antibody; Carrier Proteins; Chemokine CXCL1; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Imidazoles; Immunoglobulin G; Inflammation; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Neutrophil Infiltration; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Quinazolines; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Staphylococcal Infections; Staphylococcal Protein A; Staphylococcus aureus; Tyrphostins; Virulence Factors

2015
Staphylococcus aureus bacteremia related with erlotinib skin toxicity in a patient with pancreatic cancer.
    JOP : Journal of the pancreas, 2009, May-18, Volume: 10, Issue:3

    Topics: Bacteremia; Drug Eruptions; Erlotinib Hydrochloride; Female; Humans; Middle Aged; Pancreatic Neoplasms; Protein Kinase Inhibitors; Quinazolines; Skin; Staphylococcal Infections; Staphylococcus aureus

2009
Persistent corneal epithelial defect associated with erlotinib treatment.
    Cornea, 2009, Volume: 28, Issue:6

    Topics: Aged; Cataract Extraction; Corneal Diseases; Epithelium, Corneal; Erlotinib Hydrochloride; Female; Humans; Keratitis; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Staphylococcal Infections; Staphylococcus epidermidis

2009
Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions.
    The oncologist, 2010, Volume: 15, Issue:9

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Coagulase; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Staphylococcal Infections

2010
Staphylococcus aureus bacteremia secondary to severe erlotinib skin toxicity.
    Clinical lung cancer, 2008, Volume: 9, Issue:1

    Topics: Bacteremia; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Quinazolines; Skin; Staphylococcal Infections

2008
[Clinical study of quinoxidine--a new antibacterial preparation].
    Sovetskaia meditsina, 1973, Volume: 36, Issue:3

    Topics: Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Cyclic N-Oxides; Female; Humans; Male; Middle Aged; Muscle Cramp; Pyelonephritis; Quinazolines; Respiratory Tract Infections; Staphylococcal Infections; Vomiting

1973